Ccr2 antagonists for treatment of fibrosis

Details Ccr2 antagonists for treatment of fibrosis Ccr2 antagonists for treatment of fibrosis

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 11/00 (2006.01) A61P 17/02 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2665808

Anti-MCP-1/CCR2 antagonist therapy is provided for the control or reversal of fibrosis related diseases, including, e.g., but not limited to MCP-1/CCR2 antagonist therapy for the modulation of profibrotic markers associated with fibrotic processses including collagen matrix deposition and alveolar collapse.

Thérapie à antagoniste anti-MCP-1/CCR2 pour le contrôle ou la régression de maladies liées à la fibrose, y compris mais pas seulement la thérapie à antagoniste anti-MCP-1/CCR2 pour la modulation de marqueurs profibrotiques associés aux processsus fibrotiques englobant le dépôt de matrice de collagène et le collapsus alvéolaire.

Affiliated with

Also associated with

Rating

Ccr2 antagonists for treatment of fibrosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ccr2 antagonists for treatment of fibrosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ccr2 antagonists for treatment of fibrosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1636712